CymaBay Therapeutics Current Ratio 2011-2026 | CBAY

Annual Current Ratio CymaBay Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
3.05	1.34	2.92	13.8	10.6	11.4	5.4	1.26	2.88	1.59	2.34	0.451	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
13.8	0.451	4.76

Quarterly Current Ratio CymaBay Therapeutics

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
3.61	1.92	1.74	1.34	1.61	1.87	2.15	2.92	3.43	11.8	15.1	13.8	14.2	16.1	13.9	10.6	12.1	14.6	16.6	11.4	13.1	11.5	11.6	5.4	5.85	1.13	1.57	1.26	1.7	2.02	2.46	2.88	3.18	2.61	2.11	1.59	2.41	1.48	1.57	2.34	2.67	2.34	2.34	0.45	0.45	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
16.6	0.45	5.71

Current Ratio of other stocks in the Biotechnology industry

Issuer	Current Ratio	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	1.84	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	1.02	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	5.42	-	1.35 %	$ 17.8 M	China
Compugen Ltd. CGEN	7.46	$ 2.11	-4.95 %	$ 197 M	Israel
AgeX Therapeutics AGE	0.995	-	-10.17 %	$ 12.2 K	USA
Coherus BioSciences CHRS	1.31	$ 1.49	-5.71 %	$ 175 M	USA
I-Mab IMAB	8.96	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	3.86	-	-	$ 2.18 B	USA
Alexion Pharmaceuticals, Inc. ALXN	3.59	-	-	$ 40.3 B	USA
Genfit SA GNFT	0.922	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	1.34	-	-13.47 %	$ 169 M	France
AstraZeneca PLC AZN	1.75	-	-	$ 96.9 B	Britain
BioNTech SE BNTX	7.95	$ 88.43	-1.3 %	$ 21.4 B	Germany
EyeGate Pharmaceuticals, Inc. EYEG	1.02	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	1.43	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	0.796	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	3.2	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	11.2	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	2.68	-	-18.52 %	$ 27.3 M	Britain
CRISPR Therapeutics AG CRSP	6.6	$ 52.04	-8.62 %	$ 4.68 B	Schweiz
Affimed N.V. AFMD	1.69	-	-34.95 %	$ 21.5 M	Germany
Институт стволовых клеток человека ISKJ	1.04	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	8.41	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	1.88	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	2.69	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	10.4	$ 28.68	-4.18 %	$ 1.9 B	USA
Generation Bio Co. GBIO	1.59	-	-	$ 344 M	USA
IMV IMV	0.826	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	10.9	-	-	$ 3.67 B	USA
Akouos AKUS	6.18	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	6.17	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	6.09	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	2.53	-	-	$ 384 M	Britain
Gracell Biotechnologies GRCL	5.9	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	14.4	$ 14.67	-0.85 %	$ 210 M	USA
Advaxis ADXS	3.37	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	1.22	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	12.4	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	2.47	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	1.79	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	2.59	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	2.76	$ 3.17	0.32 %	$ 5.22 M	Israel
Aptose Biosciences APTO	0.269	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	2.35	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	2.39	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	2.84	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	5.43	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	1.78	$ 21.81	-0.66 %	$ 2.77 B	USA
Allena Pharmaceuticals ALNA	2.19	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	2.41	-	-11.43 %	$ 502 K	USA